menu
    • menu

    Company profile for Kenai Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kenai Therapeutics is a cutting-edge biotechnology company at the forefront of developing next-generation approaches to cure neurological disorders. The company leverages allogeneic induced pluripotent stem cell (iPSC) technology, a groundbreaking innovation that earned a Nobel Prize. iPSC technology allows scientists to manufacture various human cell types, and Kenai utilizes this platform to advance off-the-shelf neuron repl...
    Kenai Therapeutics is a cutting-edge biotechnology company at the forefront of developing next-generation approaches to cure neurological disorders. The company leverages allogeneic induced pluripotent stem cell (iPSC) technology, a groundbreaking innovation that earned a Nobel Prize. iPSC technology allows scientists to manufacture various human cell types, and Kenai utilizes this platform to advance off-the-shelf neuron replacement therapeutics. Kenai is committed to progressing a best-in-class pipeline targeting neurological diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kenai TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    San Diego, California
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kenaitx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kenaitx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kenai Pharma Gets $8M (CIRM) Grant To Develop RNDP-001
    Kenai Pharma Gets $8M (CIRM) Grant To Develop RNDP-001

    05 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kenai-therapeutics-receives-8m-grant-from-california-institute-for-regenerative-medicine-cirm-to-advance-rndp-001-for-treatment-of-idiopathic-parkinsons-disease-302652200.html

    PR NEWSWIRE
    05 Jan 2026
    Share Share
    Kenai Announces First Patient Dosed in Phase 1 REPLACE Trial
    Kenai Announces First Patient Dosed in Phase 1 REPLACE Trial

    15 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kenai-therapeutics-announces-first-patient-dosed-in-phase-1-replace-clinical-trial-of-neuron-replacement-cell-therapy-rndp-001-for-idiopathic-parkinsons-disease-302640518.html

    PR NEWSWIRE
    15 Dec 2025
    Share Share
    Kenai Therapeutics Opens Research Facility At Lilly Gateway Labs
    Kenai Therapeutics Opens Research Facility At Lilly Gateway Labs

    12 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250212088159/en

    BUSINESSWIRE
    12 Feb 2025
    Share Share
    Kenai Therapeutics Establishes Patient Advisory Board
    Kenai Therapeutics Establishes Patient Advisory Board

    14 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241114845802/en

    BUSINESSWIRE
    14 Nov 2024
    Share Share
    Kenai Therapeutics Appoints Dr. Derek Hei as CTO
    Kenai Therapeutics Appoints Dr. Derek Hei as CTO

    23 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241023951664/en

    BUSINESSWIRE
    23 Oct 2024
    Share Share
    Kenai Therapeutics Announces $82 Million Series A Financing
    Kenai Therapeutics Announces $82 Million Series A Financing

    29 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240229997334/en

    BUSINESSWIRE
    29 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search